Shu Y - Search Results

1

Circ_0072088 Promotes Proliferation, Migration, and Invasion of Esophageal Squamous Cell Cancer by Absorbing miR-377.

Fang N, Shi Y, Fan Y, Long T, Shu Y, Zhou J. Fang N, et al. Among authors: shu y. J Oncol. 2020 Sep 29;2020:8967126. doi: 10.1155/2020/8967126. eCollection 2020. J Oncol. 2020. PMID: 33061973 Free PMC article.

2

MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis.

Gao W, Shen H, Liu L, Xu J, Xu J, Shu Y. Gao W, et al. Among authors: shu y. J Cancer Res Clin Oncol. 2011 Apr;137(4):557-66. doi: 10.1007/s00432-010-0918-4. Epub 2010 May 28. J Cancer Res Clin Oncol. 2011. PMID: 20508945

3

miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.

Zhu W, Zhu D, Lu S, Wang T, Wang J, Jiang B, Shu Y, Liu P. Zhu W, et al. Among authors: shu y. Med Oncol. 2012 Mar;29(1):384-91. doi: 10.1007/s12032-010-9797-4. Epub 2011 Jan 22. Med Oncol. 2012. PMID: 21258880

4

[Expression of HER-2 and leptin in gastric cancer and their clinical significance].

Geng YT, Qiu JR, Wang R, Su YT, Shu YQ, Yin YM. Geng YT, et al. Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):764-9. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22335909 Chinese.

5

CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer.

Wang S, Wu X, Zhang J, Chen Y, Xu J, Xia X, He S, Qiang F, Li A, Shu Y, Røe OD, Li G, Zhou JW. Wang S, et al. Among authors: shu y. Gut. 2013 Apr;62(4):496-508. doi: 10.1136/gutjnl-2011-301522. Epub 2012 Apr 25. Gut. 2013. PMID: 22535373

6

miR-135a/b modulate cisplatin resistance of human lung cancer cell line by targeting MCL1.

Zhou L, Qiu T, Xu J, Wang T, Wang J, Zhou X, Huang Z, Zhu W, Shu Y, Liu P. Zhou L, et al. Among authors: shu y. Pathol Oncol Res. 2013 Oct;19(4):677-83. doi: 10.1007/s12253-013-9630-4. Epub 2013 May 3. Pathol Oncol Res. 2013. PMID: 23640248 Free article.

7

WT1 promotes invasion of NSCLC via suppression of CDH1.

Wu C, Zhu W, Qian J, He S, Wu C, Chen Y, Shu Y. Wu C, et al. Among authors: shu y. J Thorac Oncol. 2013 Sep;8(9):1163-9. doi: 10.1097/JTO.0b013e31829f6a5f. J Thorac Oncol. 2013. PMID: 23945386 Free article. Clinical Trial.

8

Correlation between the expression levels of miR-1 and PIK3CA in non-small-cell lung cancer and their relationship with clinical characteristics and prognosis.

Zhao Q, Zhang B, Shao Y, Chen L, Wang X, Zhang Z, Shu Y, Guo R. Zhao Q, et al. Among authors: shu y. Future Oncol. 2014 Jan;10(1):49-57. doi: 10.2217/fon.13.242. Future Oncol. 2014. PMID: 24328409

9

Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression.

Xu TP, Huang MD, Xia R, Liu XX, Sun M, Yin L, Chen WM, Han L, Zhang EB, Kong R, De W, Shu YQ. Xu TP, et al. J Hematol Oncol. 2014 Aug 29;7:63. doi: 10.1186/s13045-014-0063-7. J Hematol Oncol. 2014. PMID: 25167886 Free PMC article.

10

CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer.

Qian Y, Pei D, Cheng T, Wu C, Pu X, Chen X, Liu Y, Shen H, Zhang W, Shu Y. Qian Y, et al. Among authors: shu y. Med Oncol. 2015 Mar;32(3):44. doi: 10.1007/s12032-015-0499-9. Epub 2015 Jan 29. Med Oncol. 2015. PMID: 25631633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,929 results

Search Page

Filters